For 2022, the 30 countries in the European Union/European Economic Area (EU/EEA) reported a total of 36 179 TB cases (8.0 per 100 000 population).

The International Union Against Tuberculosis and Lung Disease released the July 2024 issue of IJTLD OPEN – a fully-compliant, open access journal to enhance the coverage of TB and lung disease.

TB activists co-founded the 1/4/6×24 Campaign to demand the universal implementation of shorter and more effective TB regimens: as little as one month or once weekly for TB prevention, four months for drug-sensitive TB, and six months for drug-resistant TB by the end of 2024.

Most TB tests still require a trip to the clinic. Now, new technology has made it possible to test people at home. This could be a big deal for South Africa, where much TB goes undiagnosed.

Using an online Delphi process, stakeholders from academia, industry, government, funding agencies, and advocacy achieved consensus on an approach to include children and adolescents in TB diagnostic tool development and evaluation.

Community Connect, an open-access space, is a valuable addition and important highlight of The Union World Conference of Lung Health 2024.

Programs aimed at eliminating tuberculosis have improved throughout the United States, with most indicating reductions in disease incidence and higher rates of treatment completion.

Bangladesh, being densely populated, with more than 1,000 people living per square kilometre, continues to be a challenging context for control of TB. The rise of antimicrobial resistance raises the bar.

A new consortium co-led by Weill Cornell Medicine has been awarded a five-year, $31 million grant from the National Institutes of Health’s National Institute of Allergy and Infectious Diseases to accelerate the development of faster, more effective treatment regimens for tuberculosis (TB).

An "unconventional" immune response now identified by scientists from the Hackensack Meridian Center for Discovery and Innovation (CDI) is a potential new pathway for developing new vaccines for tuberculosis (TB), according to a new publication.